Liberty Health Sciences Increases Size of Bought Deal Financing

Cannabis Investing News

Liberty Health Sciences announced it had increased the size of its bought deal offering, which will now be for 9,523,810 units of the company at a price of $2.10 per unit.

Liberty Health Sciences (CSE:LHS) announced it has increased the size of its bought deal offering, which will now be for 9,523,810 units of the company at a price of $2.10 per unit.
As quoted in the press release:

Each Unit will be comprised of one common share of the Company (a “Unit Share”) and one-half of one common share purchase warrant (each whole common share purchase warrant, a “Warrant”). Each Warrant will entitle the holder thereof to purchase one common share of the Company (a “Warrant Share”) at a price of C$2.65 per Warrant Share for a period of 24 months following the Closing Date (as defined below).
The Company has also agreed to grant the Underwriters an over-allotment option to purchase an additional 1,428,571 Units at the Offering Price, exercisable in whole or in part, for a period ending 30 days from and including the Closing Date. In the event the over-allotment option is exercised in full, the aggregate gross proceeds of the Offering will be C$23,000,000.10.

Click here to read the full press release.

The Conversation (0)
×